At #ESMO26 proffered paper session 1️⃣ on #breastcancer

Final results of B-42 (15-y analysis)

Extended ET (10 vs. 5 years) confirms a modest but significant improvement in DFS, BCFI and DR

Larger benefit in DR for node+

No OS difference

No ⬆️ osteoporotic fx

@OncoAlert